FORA Capital’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.46M Buy
+86,159
New +$2.29M 0.1% 206
2025
Q2
– Sell
-17,332
Closed -$439K – 656
2025
Q1
$439K Buy
+17,332
New +$454K 0.04% 344
2023
Q2
– Sell
-191,838
Closed -$7.83M – 558
2023
Q1
$7.83M Buy
+191,838
New +$8.29M 0.78% 25
2021
Q4
– Sell
-70,438
Closed -$3.03M – 425
2021
Q3
$3.03M Buy
+70,438
New +$3.12M 0.76% 31
2021
Q1
– Sell
-17,076
Closed -$629K – 1022
2020
Q4
$629K Buy
+17,076
New +$626K 0.1% 237
2020
Q2
– Sell
-72,590
Closed -$2.25M – 1213
2020
Q1
$2.25M Buy
72,590
+2,107
+3% +$71.8K 0.49% 39
2019
Q4
$2.62M Buy
+70,483
New +$2.51M 0.26% 88

Other funds holding PFE

FORA Capital's PFE Position: Q3 2026 in Review

FORA Capital opened a new position in Pfizer (PFE) in Q3 2026: 86,159 shares worth $2.46M. The stake represents 0.1% of the portfolio and ranks #206 among its holdings. This is a return to the name: FORA Capital previously reported a position in PFE as recently as Q1 2025.

FORA Capital first reported a position in PFE in Q4 2019 and has held it in 7 quarters since. The position peaked at $7.83M in Q1 2023. 2,556 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • FORA Capital held 86,159 shares of Pfizer worth $2.46M as of Q3 2026.
  • Pfizer was a new FORA Capital position in Q3 2026.
  • Pfizer made up 0.1% of FORA Capital's portfolio in Q3 2026, its #206 holding.
  • FORA Capital first reported a position in Pfizer in Q4 2019 and has held it in 7 quarters since.
  • FORA Capital's Pfizer position peaked at $7.83M in Q1 2023.
  • 2,556 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on FORA Capital's 13F filing for Q3 2026, filed 13 Nov 2026.